Cargando…
Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial
The recent Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance (MORDOR) trial reported a reduction in child mortality following biannual azithromycin mass drug administration (MDA). Here, we investigate the financial costs and cost-effectiveness from the health provider perspectiv...
Autores principales: | Hart, John D., Kalua, Khumbo, Keenan, Jeremy D., Lietman, Thomas M., Bailey, Robin L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470598/ https://www.ncbi.nlm.nih.gov/pubmed/32342840 http://dx.doi.org/10.4269/ajtmh.19-0622 |
Ejemplares similares
-
Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020) -
Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial
por: Oron, Assaf P., et al.
Publicado: (2020) -
Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019) -
MORDOR II: Persistence of Benefit of Azithromycin for Childhood
Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019) -
Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)